Cardiology
News
Acute stroke thrombolysis worked safely despite GI bleed or malignancy
CHICAGO – Current guidelines contraindicate acute stroke thrombolysis in patients with GI bleed or malignancy, but a new analysis suggests it’s...
News
EARLY: Angiography within 2 hours of acute non-ST event cut recurrent ischemic events
Coronary angiography immediately after an acute non–ST-segment elevation coronary event limited recurrent events, compared with later intervention...
Video
ARISTOPHANES: Apixaban edges other DOACS for octogenarians
CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds...
News
Invasive strategy increased bleeding risk in frail older AMI patients
Registry analysis suggests frailty in an AMI patient calls for personalized decision making.
Clinical
Resuming DOAC therapy in AF patients after gastrointestinal bleed
For patients who develop a gastrointestinal bleed (GIB) while using direct oral anticoagulant (DOAC) therapy for atrial fibrillation (AF), does...
News
PIONEER-HF called “practice changing” for acute decompensated heart failure
CHICAGO – In-hospital initiation of sacubitril/valsartan safely and significantly reduced heart failure rehospitalizations in the next 8 weeks.
Clinical
Burden of atrial fibrillation associated with stroke risk
In patients with paroxysmal atrial fibrillation (PAF), is the burden of atrial fibrillation associated with increased risk of ischemic stroke?
Video
PIONEER-HF secures place for sacubitril/valsartan in this heart failure doc’s practice
CHICAGO – The designated discussant for the PIONEER-HF presentation points out the importance of the results.
News
Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ report
The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.
News
Lower glucose targets show improved mortality in cardiac patients
Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.